March 19, 2021 C-Path Names COO Kristen Swingle Interim President Joseph Scheeren departing the organization after two years of strong leadership TUCSON, Ariz., March 19, 2021 — Critical Path In
March 18, 2021 Welcome Dr. Martijn Muller as CPP Senior Scientific Director C-Path is pleased to welcome Martijn Muller, PhD, as Senior Scientific Director for the Critical Path for Parkinson Consortium. Pr
March 18, 2021 A metadata-driven tool to determine the robustness of digital health technologies assessments for Parkinson’s Disease leveraging the voice of the patient – Sakshi Sardar, et al. Abstract # 1314
March 18, 2021 Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease – Derek Hill, et al. Abstract # 1289
March 18, 2021 Identifying and Controlling Variability in Digital Health Measures in Parkinson’s Disease Clinical Trials – George Roussos, et al. Abstract # 342
March 18, 2021 Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium – Martijn Müller, et al. Abstract # 341
March 18, 2021 The Development of a Parkinson’s Disease Biomarker Inventory Dashboard – Michael Pauley, et al. Abstract # 308
March 18, 2021 Model Innovation in Parkinson’s Disease Drug Development: Linking Quantitative Systems Pharmacology to the Patient Voice – Jeff Barrett, et al. Abstract # 287
March 18, 2021 Considerations for Participation in PPP Projects: Learnings from the Critical Path for Parkinson’s Consortium, D. Stephenson Session: # S0802-L, Understanding of Different Set Ups of PPP, Benefits of PPPs and Learnings of Recent Projects to Facilitate
March 10, 2021 C-Path Program and Consortia Leaders Selected to Serve in Sr. Vice President and Vice President Roles Inish O’Doherty and Sudhir Sivakumaran will lead new programs; Stephen Joel Coons and John-Michael Sauer move into Sr. VP roles.